1. Inicio
  2. Proyectos y Estudios
  3. Phase 3, double-blind, placebo-controlled, multicentre study on the efficacy and safety of human plasma derived antithrombin (Atenativ) in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass.

Phase 3, double-blind, placebo-controlled, multicentre study on the efficacy and safety of human plasma derived antithrombin (Atenativ) in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass.

Datos básicos

ENSAYO CLÍNICO ATN-108 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2024

Documentos

  • No hay documentos

Participantes

Ver todos los Investigadores

Grupos

Financiadores - Promotores

OCTAPHARMA

Cita

Compartir